A Stronger Year for Angel Investing? NYA's $15M YTD Outpaces 2025: NYA News - October 2026Read Now: Interviews with NYA's Dan Zitting and Dugu Systems Co-Founder and CEO Adam Brenner, Investment with Rheoxtech, and more
New York Angels Members wrapped up the third quarter with $15 million invested year-to-date, which already surpassed the group's total investment in 2025. Read this edition of the newsletter to see the similar trend across early-stage investments and venture funding, as well as the latest investments, portfolio milestones, and news from across our New York Angels community.
New York Angels Members invested $15 million year-to-date in 2026.
SEPTEMBER INVESTMENT HIGHLIGHTS
Rheoxtech is developing innovative medical technology that helps prevent additional heart damage when blood flow is restored to the heart. Its catheter-based Rheox system is designed to deliver controlled reoxygenation during treatment. Kenny Nova, Troy Sarich, and John Younger were the deal leads.
FOUNDER SPOTLIGHT
Adam Brenner is the Co-Founder and CEO of Dugu Systems, a hard-tech company developing technology to make decarbonized power the most economical choice for industrial customers. In this interview, Adam discusses how New York Angels Members Tom Hirschfeld and Tom Blum became valuable advisors that transformed their fundraising journey, how New York Angels' efficient process helped close the round quickly, and why founders need to have a problem statement and the solution that match the thesis of the investor.
PORTFOLIO NEWS
CYNOMI
Cynomi announced the winners of its 2026 Cyber Advisory Excellence Awards, recognizing cybersecurity service providers for outstanding innovation and leadership. The awards highlight organizations advancing cybersecurity advisory services and helping businesses strengthen their security strategies. Read Now
PORTFOLIO NEWS
OSTEOBOOST
Osteoboost secured its seventh U.S. patent, strengthening intellectual property protection for its FDA-cleared wearable device designed to slow bone density loss. The new patent protects its personalized vibration technology, reinforcing the company's competitive advantage as it expands in the bone health market. Read Now
PORTFOLIO NEWS
STIMCARDIO
StimCardio reported promising results from its NeuroPulse study, demonstrating a substantial reduction in recurrent atrial fibrillation following cardiac ablation. The findings highlight the potential of its non-invasive wearable technology to improve patient outcomes and reduce the need for additional treatments. Read Now
PORTFOLIO NEWS
VIVIFI MEDICAL
Vivifi Medical was named one of just 14 companies selected from more than 2,100 applicants for Pepperdine Graziadio's 2026 Most Fundable Companies list. The recognition highlights the company's investment potential and innovative approach to treating enlarged prostate conditions through minimally invasive technology. Read Now
NYA MEMBER SPOTLIGHT
Dan Zitting joined New York Angels in 2022 with a background as a software entrepreneur and operator whose journey allowed him to explore many different ways of building software companies, from bootstrapping to venture capital to large private equity. In this interview, Dan discusses the value of investing in industries that are outside of his expertise, why founders should consider raising the minimum needed, and how intellectual stimulation provides an additional return on investment for New York Angels Members.
CRUNCHBASE GLOBAL VENTURE FUNDING JUMPS 122%
Global venture funding surged 122% year over year to $42 billion in August 2026, according to Crunchbase. While angel, seed, and early-stage funding represented a smaller share of total capital, the data highlights significant growth in early-stage investments, an increasingly concentrated investment landscape, and the important role of early-stage investors in identifying tomorrow's market leaders.
UPCOMING MEMBER MEETINGS
Investment Forum (Hybrid):
• November 16th (9:00 AM - 12:30 PM)
Screening (Hybrid):
• November 2nd (9:00 AM - 1:00 PM)
FOUNDER DEADLINES
December Screening Application:
• November 8th
*New York Angels, Inc. ("NYA") is a not-for-profit corporation that is funded by membership dues for individuals and/or entities that NYA has designated as members as well as from certain sponsors. Its purposes include providing administrative support to its members. NYA does not invest in companies. Investments, if made, are made by individual members of NYA.
